A Study With Self-administered Rocatinlimab in Adolescent and Adult Participants With Moderate-to-severe Atopic Dermatitis
Public ClinicalTrials.gov record NCT06224192. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multicenter, Randomized, Open-label, Performance Study With Self-administered Subcutaneous Rocatinlimab (AMG 451) in Adolescent and Adult Subjects With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Outpost)
Study identification
- NCT ID
- NCT06224192
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Amgen
- Industry
- Enrollment
- 151 participants
Conditions and interventions
Conditions
Interventions
- Rocatinlimab AI Combination Product
- Rocatinlimab Prefilled Syringe Combination Product
Combination Product
Eligibility (public fields only)
- Age range
- 12 Years to 100 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 1, 2024
- Primary completion
- Apr 10, 2025
- Completion
- Mar 15, 2026
- Last update posted
- Mar 24, 2026
2024 – 2026
United States locations
- U.S. sites
- 22
- U.S. states
- 13
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Kern Research Inc | Bakersfield | California | 93301 | — |
| Long Beach Research Institute | Long Beach | California | 90805 | — |
| Dermatology Research Associates | Los Angeles | California | 90045 | — |
| Havana Research Institute Inc | Pasadena | California | 91105 | — |
| Integrative Skin Science and Research | Sacramento | California | 95815 | — |
| Direct Helpers Research Center | Hialeah | Florida | 33012 | — |
| Anchor Medical Research | Miami | Florida | 33176 | — |
| Hamilton Research, LLC | Alpharetta | Georgia | 30022 | — |
| Treasure Valley Medical Research | Boise | Idaho | 83706 | — |
| Dermatology and Skin Cancer Center Leawood | Leawood | Kansas | 66211 | — |
| Excel Clinical Research | Las Vegas | Nevada | 89109 | — |
| Las Vegas Clinical Trials | North Las Vegas | Nevada | 89030 | — |
| Skin Cancer and Dermatology Institute | Reno | Nevada | 89509 | — |
| The Skin Surgery Center for Clinical Research | Winston-Salem | North Carolina | 27103 | — |
| Bexley Dermatology Research | Bexley | Ohio | 43209 | — |
| Apex Clinical Research Center LLC | Mayfield Heights | Ohio | 44124 | — |
| Essential Medical Research LLC | Tulsa | Oklahoma | 74137 | — |
| Health Concepts | Rapid City | South Dakota | 57702 | — |
| Cumberland Skin Center | Hermitage | Tennessee | 37076 | — |
| Sms Clinical Research Limited Liability Company | Mesquite | Texas | 75149 | — |
| Texas Dermatology Research Center | Plano | Texas | 75025 | — |
| Virginia Dermatology and Skin Cancer Center | Norfolk | Virginia | 23502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 25 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06224192, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 24, 2026 · Synced May 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06224192 live on ClinicalTrials.gov.